Key Points Penumbra topped analyst forecasts with $339.5 million in GAAP revenue and $0.86 non-GAAP EPS, driven by double-digit U.S. thrombectomy growth. Gross margin (GAAP) expanded sharply to 66.0%, ...

Inari Medical — now part of Stryker (NYSE: SYK) + — today announced the launch of its next-generation InThrill thrombectomy system. The company describes InThrill as the first and only purpose-built ...

What Happened? Shares of medical device company Penumbra (NYSE:PEN) jumped 11.8% in the afternoon session after the company ...

Inari Medical, now part of Stryker, announced the launch of its next-generation InThrill thrombectomy system. According to ...

该研究开发出了一种清除血栓的新技术——微型旋流取栓术（Milli-spinner thrombectomy），其效果是现有技术的 2 倍多，为快速、简便且彻底清除血栓 ...

动脉或静脉中的血栓阻塞可能引发致命疾病。传统机械取栓术 (mechanical thrombectomy, MT)虽能通过抽吸、支架取栓 (stent retriever)或切割机制治疗缺血性卒中、心肌梗死 (MI)等疾病，但对富含纤维蛋白 (fibrin)的大血栓清除率有限，且存在血栓碎裂引发远端栓塞的风险。 新型微米级旋转取栓装置 (milli-spinner ...

InterVene’s Recana has been specifically designed to address the long-term complications associated with chronic venous ...

Explore Penumbra's Q2 2025 earnings highlights, featuring 13.4% growth, U.S. thrombectomy success, RUBY XL launch insights, and updated revenue guidance.

Penumbra Inc (PEN) reports a 13.4% revenue increase, driven by US thrombectomy success, while navigating international ...

The ICB's acting medical director, Dr Andy Knox, told the meeting the hospital had now recruited enough interventional ...

A potentially life-saving stroke treatment will be on offer around the clock in Lancashire by early next year at the latest, ...